Anacor (ANAC) Approves 3.25M Common Offering
Anacor Pharmaceuticals (Nasdaq: ANAC), today announced the sale of 3.25 million shares of its common stock for gross proceeds of $21,450,000 pursuant to an underwriting agreement with Canaccord Genuity acting as the sole bookrunner. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 487,500 shares of common stock to cover over-allotments, if any.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Versartis (VSAR) Prices 4.9M Offering of Common Stock at $12.25/Share
- xG Technology (XGTI) Files 1.67M Common Stock Shelf for Selling Shareholders
- Mimecast Limited (MIME) Prices 4M Secondary Offering at $16.50/Share